Labelling Review row-Online
Labelling Review row-Online
Labelling Review row-Online
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Mast Cell Tryptase<br />
Clone 10D11<br />
7 mL Bond ready-to-use PA0019 P<br />
For In Vitro Diagnostic Use<br />
Mast cells contain a number of preformed chemical mediators such as<br />
histamine, chymase, carboxypeptidase and proteolytic tryptase. A<br />
substantial quantity of tryptase is reported to be found in mast cells of skin<br />
and lung and suggests this enzyme plays a major role in mast cell mediated<br />
events. In vitro studies indicate tryptase can cleave C3 to form C3a<br />
anaphylatoxin, inactivate fibrinogen as a coaguable substrate for thrombin<br />
and activate latent collagenase. Models of allergenic disease in the skin,<br />
nose and lung have each indicated elevated tryptase levels. Human mast<br />
cell tryptase has been reported to be implicated as a mediator of<br />
inflammation. Mast cell degranulation in the gut causes mucus secretion,<br />
mucosal edema, increased gut permeability and may be responsible for<br />
some of the symptoms and signs of inflammatory bowel disease.<br />
Also available as a Novocastra concentrate, refer to page 130.<br />
Bowel: immunohistochemical staining with Bond ready-to-use Mast Cell Tryptase (10D11)<br />
using Bond Polymer Refine Detection.<br />
Melan A<br />
Clone A103<br />
7 mL Bond ready-to-use PA0233 P (HIER)<br />
For In Vitro Diagnostic Use<br />
Melan A, a product of the MART-1 gene, is a melanocytic differentiation<br />
marker recognized by autologous cytotoxic T lymphocytes.<br />
Product Specific Information<br />
Melan A (A103) is employed in the assessment of Melan A in melanocytic<br />
lesions.<br />
Also available as a Novocastra concentrate, refer to page 132.<br />
Malignant melanoma: immunohistochemical staining with Bond ready-to-use Melan A (A013)<br />
using Bond Polymer Refine Detection.<br />
Mesothelin<br />
Clone 5B2<br />
7 mL Bond ready-to-use PA0373 P (HIER)<br />
For In Vitro Diagnostic Use<br />
Mesothelin is present on the surface of mesothelial cells, mesothelioma,<br />
epithelial ovarian cancers and some squamous cell carcinomas. Mesothelin<br />
is abundantly expressed in the kidney and in occasional epithelial cells of<br />
the trachea, tonsil and fallopian tube. The function of mesothelin is unclear<br />
but it may have a role in cellular adhesion.<br />
Product Specific Information<br />
Mesothelin is reported to be abundant in the normal mesothelial cells from<br />
which malignant mesothelioma and ovarian cystadenocarcinomas are<br />
derived. As such, Bond ready-to-use Mesothelin (5B2) is recommended for<br />
use as part of a panel of antibodies to distinguish mesotheliomas and ovarian<br />
cystadenocarcinomas from other solid tumors.<br />
Mesothelin (5B2) is recommended for use as part of a panel of antibodies to<br />
distinguish mesotheliomas and ovarian cystadenocarcinomas from other<br />
solid tumors.<br />
Also available as a Novocastra concentrate, refer to page 133.<br />
Mesothelioma: immunohistochemical staining with Bond ready-to-use Mesothelin (5B2) using<br />
Bond Polymer Refine Detection.<br />
MLH1 (Mismatch Repair Protein)<br />
Clone ES05 New!<br />
7 mL Bond ready-to-use PA0610 P (HIER)<br />
For In Vitro Diagnostic Use<br />
MLH1, a mismatch repair protein involved in maintaining the integrity of<br />
genetic information, alongside MSH2, MSH6 and PMS2. During DNA<br />
replication, strand misalignment can occur resulting in alterations to<br />
microsatellite repeats, often referred to as microsatellite instability (MSI).<br />
These defects in DNA repair pathways have been linked to human<br />
carcinogenesis. Mutations in the MLH1 gene have been reported to be<br />
found in tumors with MSI, such as some forms of colon cancer eg<br />
Hereditary nonpolyposis colon cancer (HNPCC), a subset of sporadic<br />
carcinomas and breast cancer. Loss of expression of MLH1 has also been<br />
reported in acute lymphoblastic leukemia, endometrial carcinoma, gastric<br />
carcinoma and ovarian carcinoma.<br />
Also available as a Novocastra concentrate, refer to page 134.<br />
F Frozen I Immunofluorescence E Electron microscopy<br />
P Paraffin C Flow cytometry O Other applications<br />
W Western blotting<br />
/33<br />
Bond